Guardian Pharmacy ServicesGRDN -0.24%42 ROE % is 24.93% as of Mar. 2026, which is 55% below its 10-year median of 55.56. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 623 Healthcare Providers & Services companies, Guardian Pharmacy Services ranks better than 91.17% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Guardian Pharmacy Services's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardian Pharmacy Services ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's ROE % distribution charts can be found below:
* The bar in red indicates where Guardian Pharmacy Services's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Guardian Pharmacy Services (GRDN) has a ROE % of 24.93% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Guardian Pharmacy Services and its competitors. This is 55% below median its historical median of 55.56. According to the industry distribution chart, Guardian Pharmacy Services ranks #55 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 8.8%.
Is Guardian Pharmacy Services' ROE % too high?
Guardian Pharmacy Services' current ROE % of 24.93% is 55% below median its 10-year median of 55.56. The Healthcare Providers & Services industry median ROE % is 5.88. Guardian Pharmacy Services' value of 24.93% is 324% above this industry median. Based on the distribution chart, Guardian Pharmacy Services ranks #55 out of 623 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' ROE % compare to ACHC and ASTH?
According to the Healthcare Providers & Services industry distribution chart, Guardian Pharmacy Services ranks #55 out of 623 companies for ROE %. This places Guardian Pharmacy Services in the top 9% of its industry — outperforming the majority of peers. The industry median ROE % is 5.88. Guardian Pharmacy Services' value of 24.93% is 324% above this benchmark. While the company's 10-year median is 55.56 vs. the industry median of 5.88, Guardian Pharmacy Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardian Pharmacy Services's current ROE % of 24.93% is 324% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Guardian Pharmacy Services and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardian Pharmacy Services's current ROE % is 24.93%, which is 55% below median its own 10-year median of 55.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current ROE % of 24.93%. The current ROE % is 24.93%, which is 55% below median its 10-year median of 55.56 and 324% above the Healthcare Providers & Services industry median of 5.88. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current ROE % is 24.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score
Get the complete analysis for GRDN
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRDN has been successfully added to your 
